Format

Send to

Choose Destination
Lancet. 2000 Mar 11;355(9207):863-4.

Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Author information

1
Department of Hypertension, Ochsner Medical Institutions, New Orleans, LA 70121, USA.

Erratum in

  • Lancet 2000 Apr 8;355(9211):1280.
PMID:
10752699
DOI:
10.1016/s0140-6736(00)00092-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center